Clinical trial
A Post Approval Study to Evaluate the Safety and Effectiveness of Cartiva Implant in the Treatment of First Metatarsophalangeal Joint Osteoarthritis as Compared to a Control
NCT02978573 is registered in ClinicalTrials.gov with Cartiva, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Post Approval Study to Evaluate the Safety and Effectiveness of Cartiva Implant in the Treatment of First Metatarsophalangeal Joint Osteoarthritis as Compared to a Control
- Lead sponsor
- Cartiva, Inc.
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- October 31, 2016
- Completion date
- April 27, 2018
- Enrollment
- 135 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
osteoarthritis of first metatarsalphalangeal joint